These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

610 related items for PubMed ID: 12627501

  • 1. Hormone replacement therapy containing progestins and given continuously increases breast carcinoma risk in Sweden.
    Olsson HL, Ingvar C, Bladström A.
    Cancer; 2003 Mar 15; 97(6):1387-92. PubMed ID: 12627501
    [Abstract] [Full Text] [Related]

  • 2. A population-based cohort study of HRT use and breast cancer in southern Sweden.
    Olsson H, Bladström A, Ingvar C, Möller TR.
    Br J Cancer; 2001 Sep 01; 85(5):674-7. PubMed ID: 11531250
    [Abstract] [Full Text] [Related]

  • 3. Age and menopausal effects of hormonal birth control and hormone replacement therapy in relation to breast cancer risk.
    Shantakumar S, Terry MB, Paykin A, Teitelbaum SL, Britton JA, Moorman PG, Kritchevsky SB, Neugut AI, Gammon MD.
    Am J Epidemiol; 2007 May 15; 165(10):1187-98. PubMed ID: 17337757
    [Abstract] [Full Text] [Related]

  • 4. [Estrogen replacement therapy and breast cancer].
    Bakken K, Alsaker E, Eggen AE, Lund E.
    Tidsskr Nor Laegeforen; 2005 Feb 03; 125(3):282-5. PubMed ID: 15702147
    [Abstract] [Full Text] [Related]

  • 5. Sex steroid hormones and breast cancer: is there a link with oral contraceptives and hormone replacement therapy?
    Khoo SK, Chick P.
    Med J Aust; 1992 Jan 20; 156(2):124-32. PubMed ID: 1736053
    [Abstract] [Full Text] [Related]

  • 6. Association of hormone replacement therapy to estrogen and progesterone receptor status in invasive breast carcinoma.
    Chen WY, Hankinson SE, Schnitt SJ, Rosner BA, Holmes MD, Colditz GA.
    Cancer; 2004 Oct 01; 101(7):1490-500. PubMed ID: 15378477
    [Abstract] [Full Text] [Related]

  • 7. Hormone replacement therapy use and variations in the risk of breast cancer.
    Opatrny L, Dell'Aniello S, Assouline S, Suissa S.
    BJOG; 2008 Jan 01; 115(2):169-75; discussion 175. PubMed ID: 18081598
    [Abstract] [Full Text] [Related]

  • 8. Association of regimens of hormone replacement therapy to prognostic factors among women diagnosed with breast cancer aged 50-64 years.
    Daling JR, Malone KE, Doody DR, Voigt LF, Bernstein L, Marchbanks PA, Coates RJ, Norman SA, Weiss LK, Ursin G, Burkman RT, Deapen D, Folger SG, McDonald JA, Simon MS, Strom BL, Spirtas R.
    Cancer Epidemiol Biomarkers Prev; 2003 Nov 01; 12(11 Pt 1):1175-81. PubMed ID: 14652277
    [Abstract] [Full Text] [Related]

  • 9. Hormone replacement therapy containing progestins and given continuously increases breast carcinoma risk in Sweden.
    Shah NR.
    Cancer; 2003 Oct 01; 98(7):1552-3; author reply 1553. PubMed ID: 14508845
    [No Abstract] [Full Text] [Related]

  • 10. Tamoxifen, hormone receptors and hormone replacement therapy in women previously treated for breast cancer: a cohort study.
    Dew JE, Wren BG, Eden JA.
    Climacteric; 2002 Jun 01; 5(2):151-5. PubMed ID: 12051110
    [Abstract] [Full Text] [Related]

  • 11. Absence of an effect of injectable and implantable progestin-only contraceptives on subsequent risk of breast cancer.
    Strom BL, Berlin JA, Weber AL, Norman SA, Bernstein L, Burkman RT, Daling JR, Deapen D, Folger SG, Malone KE, Marchbanks PA, Simon MS, Ursin G, Weiss LK, Spirtas R.
    Contraception; 2004 May 01; 69(5):353-60. PubMed ID: 15105056
    [Abstract] [Full Text] [Related]

  • 12. Breast cancer in postmenopausal women with and without hormone replacement therapy: preliminary results of the MISSION study.
    Espié M, Mares P, de Reilhac P, Chevallier T, Daurès JP.
    Gynecol Endocrinol; 2006 Aug 01; 22(8):423-31. PubMed ID: 17012103
    [Abstract] [Full Text] [Related]

  • 13. Risk of breast cancer in post-menopausal women using hormone replacement therapy.
    Ratanawichitrasin A, Reansuwan W, Ratanawichitrasin S, Bhodhisuwan K, Kongpatanakul S.
    J Med Assoc Thai; 2002 May 01; 85(5):583-9. PubMed ID: 12188389
    [Abstract] [Full Text] [Related]

  • 14. Hormone replacement therapy and breast cancer risk in California.
    Coombs NJ, Taylor R, Wilcken N, Fiorica J, Boyages J.
    Breast J; 2005 May 01; 11(6):410-5. PubMed ID: 16297085
    [Abstract] [Full Text] [Related]

  • 15. Impact of hormone replacement therapy on the histologic subtype of breast cancer.
    Zanetti-Dällenbach RA, Krause EM, Lapaire O, Gueth U, Holzgreve W, Wight E.
    Arch Gynecol Obstet; 2008 Nov 01; 278(5):443-9. PubMed ID: 18335229
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Prior hormone therapy and breast cancer risk in the Women's Health Initiative randomized trial of estrogen plus progestin.
    Anderson GL, Chlebowski RT, Rossouw JE, Rodabough RJ, McTiernan A, Margolis KL, Aggerwal A, David Curb J, Hendrix SL, Allan Hubbell F, Khandekar J, Lane DS, Lasser N, Lopez AM, Potter J, Ritenbaugh C.
    Maturitas; 2006 Sep 20; 55(2):103-15. PubMed ID: 16815651
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.